Lung Cancer Screening Market Scope, Growth Analysis and Industry Forecast 2030

1
Lung Cancer Screening Market Size Worth USD 5.69
Billion in 2030
Increasing incidence of lung cancer, in turn,
rising demand for early diagnosis is a key factor
driving lung cancer screening market revenue
growth
www.emergenresearch.com
. 2
2
Our Model
Market Analysis
Financial Analysis
Distribution Channel Analysis
Brand Analysis
Custom Market Intelligence
Competitor Analysis
Product Analysis
Custom Research
www.emergenresearch.com
Demand Analysis
Risk Analysis
3
Business Plan Parameters
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel Feasibility
www.emergenresearch.com
Customer Identification Survey
Competitive Landscape / MA Feasibility
www.emergenresearch.com
4
Industries We Cater to
www.emergenresearch.com
5
5
Market Summary
The global Lung Cancer Screening Market size was
USD 2.80 Billion in 2021 and is expected to
register a revenue CAGR of 8.1 during the
forecast period, according to latest analysis by
Emergen Research. High cigarette consumption
increasing incidence of lung cancer is a major
factor driving market revenue growth. Lung
cancer is one of the main causes of cancer death,
accounting for around 25 of all cancer
fatalities. Cigarette smoking has been identified
as a significant risk factor for developing
Non-Small Cell Lung Cancer (NSCLC), along with
other environmental and genetic risk factors.
Approximately 80 of lung cancer fatalities are
caused by smoking, with remaining being caused by
secondhand smoke exposure. According to World
Health Organization, rise in worldwide tobacco
consumption, particularly in Asia, is responsible
for a continued rise in lung cancer mortality. In
addition, lung cancer cases has been increased
due to factors such as water pollution, age,
radiation exposure, air pollution (polycyclic
aromatic hydrocarbons), and prolonged exposure to
certain chemicals, gases, or pollutants including
asbestos, beryllium, arsenic, nickel, and
chromium. With the advent of genetic and
biomarker testing, which has several potential
prospects in the market, certain mutations have
been found for better-personalized target
treatment for patients, thus, there is a rise in
demand for lung cancer screening for early
diagnosis, which is driving revenue growth of the
market.  Read More https//www.emergenresearch.
com/industry-report/lung-cancer-screening-market
www.emergenresearch.com
6
Market Summary
Some Key Findings From the Report The Non-Small
Cell Lung Cancer (NSCLC) segment accounted for
largest revenue share in 2021. In Asian
countries, rapid industrial expansion and
suburbanization are factors contributing to
rising frequency of NSCLC and increasing need for
therapy. Early-stage diagnosis can increase
5-year survival to 80, which is expected to have
significant benefits for outlook of NSCLC, as a
result, there is an increasing demand for lung
screening technology for early diagnosis, which
is driving revenue growth of this segment.  The
Low Dose spiral CT (LDCT) scan segment accounted
for largest revenue share in 2021. Since the
development of LDCT scan, 8090 of instances of
early-stage, invasive stage I lung cancer can be
identified reducing mortality from lung
cancer. The diagnostic centers segment accounted
for a moderate revenue share in 2021. For elderly
people, diagnostic centers are an ideal
alternative since they offer individualized
treatment and reduce need for repeated hospital
visits. In addition to having more control over
scheduling of procedures, outpatient surgery
facilities can be 4560 less expensive than
hospitals, which benefits patients, insurance,
and taxpayers equally. As a consequence, compared
to unexpected hospital events, very few surgeries
may need to be postponed or rescheduled.
  Request Free Sample _at_ https//www.emergenresear
ch.com/request-sample/1328
www.emergenresearch.com
7
Market Summary
Market Segmentation Cancer Type Outlook
(Revenue, USD Billion 2019-2030) Non-small Cell
Lung Cancer (NSCLC) Small Cell Lung
Cancer Diagnosis Type Outlook (Revenue, USD
Billion 2019-2030) Low Dose Spiral CT Scan Chest
X-Ray End-use Outlook (Revenue, USD Billion
2019-2030) Hospitals Clinics Diagnostic
Centers Request customization _at_
https//www.emergenresearch.com/request-for-custom
ization/1328
8
Parameter Details
Market Size Estimation Period 2020-2028
Base Year Considered 2020
Historical Data 2017-2019
Forecast Period 2021-2028
Quantitative Units Revenue in USD million CAGR from 2020 to 2028
Segments Covered Types, Application, End-Users, Regions more.
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization expert consultation
Pricing and Purchase Options Explore Different Purchase Options Request for Discount to Avail New Year Discount
MARKET SEGMENTATION
www.emergenresearch.com
9
Regional Share Dynamics
www.emergenresearch.com
10
LATEST PUBLICATIONS
Disposable Syringes Market https//www.emergenrese
arch.com/industry-report/disposable-syringes-marke
t Medical Footwear Market https//www.emergenrese
arch.com/industry-report/medical-footwear-market
Microneedling Market https//www.emergenresearch.c
om/industry-report/microneedling-market Mass
Spectrometry Market https//www.emergenresearch.co
m/industry-report/mass-spectrometry-market Custom
Antibody Market https//www.emergenresearch.com/i
ndustry-report/custom-antibody-market Automated
Parking System Market https//www.emergenresearch.
com/industry-report/automated-parking-system-marke
t Smart Transportation Market https//www.emergen
research.com/industry-report/smart-transportation-
market  
www.emergenresearch.com
11
At Emergen Research, we believe in advancing with
technology. We are a growing market research and
strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted
to become more prevalent in the coming
decade. Our expertise umbrellas the
technological environment of all major
industries, and our services help you map your
actions to ensure optimal yield. Our analysts
utilize their market proficiency to offer
actionable insights that help our clients
implement profitable strategies and optimize
their return on investment. Our services are
wide-ranging, right from technological
environment analysis to technological profiling
that highlights the existing opportunities in the
market you can capitalize on to stay ahead of
your competitors.
About Us
www.emergenresearch.com
12
Lets Talk Contact Information
Reach out to us and our Research Executives will
ensure you get the report that meets all your
requirements and address all your concerns.
14671 110 Avenue, Surrey, British Columbia, V3R2A9
www.emergenresearch.com
www.emergenresearch.com
sales_at_emergenresearch.com
1 [phone]